Vaccines

A Lassa fever vaccine candidate shows promise in animal studies, with guinea pigs 100 percent protected from lethal virus exposure.

Robert F Kennedy Jr’s recent speech suggests that investigations into childhood vaccines and over-medication could be on the cards.

So much has already been achieved with RNA – and it’s only going to get better.

Senate committee votes in favor of the nomination; full Senate vote will be next.

With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?

A curated collection of articles examining critical questions and advancements in vaccine science and policy.

Why we need to shift from reactive to proactive measures in tackling global health challenges.

Maintaining the stability of vaccines over time and during temperature excursions is a crucial aspect of production, transport, and delivery.

RNA sequence design is emerging as a path to transform the economics and methodologies of RNA as a drug modality.

How whole genome sequencing is being used to understand the bacterium that causes syphilis – and what it means for vaccine development.